Foundation Medicine Revenues Rise 93 Percent in Q4 | GenomeWeb

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market Tuesday that its fourth quarter revenues rose 93 percent year over year and its clinical test volume also grew 93 percent.

The firm reported total revenues of $18.7 million for the three months ended Dec. 31, up from $9.7 million in Q4 2013, exceeding the consensus Wall Street estimate of $18.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.